Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifapentine in AIDS Patients With MAC Bacteremia
NCT00002192Phase 2Completed
- Sponsor
- Anderson Clinical Research
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifapentine in Mycobacterium avium complex infection (MAC), sponsored by Anderson Clinical Research. Status: completed.
02
Drugs
rifapentine
03
Conditions
Mycobacterium avium complex infection (MAC)
Beyond the preview
Go deeper on NCT00002192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002192.